Resmed (RMD) - Investment that lets you sleep at night...Quant Buy ($5.60)....published July 2013....not much has changed

Mathan Somasundaram

Deep Data Analytics

Resmed (RMD) - Investment that lets you sleep at night...Quant Buy ($5.60)....published July 2013....not much has changed. We rate RMD as Quant BUY with Quant Target Price (QTP) of $5.60. RMD has been a consistent outperformer during reporting periods as well as one of the best mid cap defensive beta stocks against the market. Despite trading at high multiples, RMD offers a stable quality healthcare business model with low gearing and double digit growth in an environment of expanding global demand. Given the bad press regarding cheap health care alternatives, market still values long term sustainable quality health care service providers. The consistent ability of RMD to deliver solid results and defensive nature will be hard to ignore for the market that is chasing earnings certainty. (VIEW LINK)


Mathan Somasundaram
Founder & CEO
Deep Data Analytics

Over 25 years’ experience in the finance/tech industry. Mathan has worked extensively in all parts of the finance sector (i.e. County NatWest, Citi, LIM, Southern Cross, Bell Potter, Baillieu Holst and Blue Ocean Equities). Currently Founder and...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.